4//SEC Filing
Kirby John J. 4
Accession 0001415889-22-000791
CIK 0000861838other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 8:41 PM ET
Size
5.8 KB
Accession
0001415889-22-000791
Insider Transaction Report
Form 4
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-24+25,000→ 25,000 totalExercise: $0.57Exp: 2032-01-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 24, 2022. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 24, 2023 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001556327
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 8:41 PM ET
- Size
- 5.8 KB